Annual Accounts Payable:
$77.87M-$24.88M(-24.22%)Summary
- As of today, JAZZ annual accounts payable is $77.87 million, with the most recent change of -$24.88 million (-24.22%) on December 31, 2024.
 - During the last 3 years, JAZZ annual accounts payable has fallen by -$22.43 million (-22.36%).
 - JAZZ annual accounts payable is now -24.22% below its all-time high of $102.75 million, reached on December 31, 2023.
 
Performance
JAZZ Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Accounts Payable:
$89.37M-$6.56M(-6.84%)Summary
- As of today, JAZZ quarterly accounts payable is $89.37 million, with the most recent change of -$6.56 million (-6.84%) on June 30, 2025.
 - Over the past year, JAZZ quarterly accounts payable has dropped by -$7.73 million (-7.96%).
 - JAZZ quarterly accounts payable is now -28.77% below its all-time high of $125.45 million, reached on March 31, 2023.
 
Performance
JAZZ Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
JAZZ Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | 
|---|---|---|
| 1Y1 Year | -24.2% | -8.0% | 
| 3Y3 Years | -22.4% | +20.5% | 
| 5Y5 Years | +63.8% | +78.6% | 
JAZZ Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -24.2% | at low | -28.8% | +14.8% | 
| 5Y | 5-Year | -24.2% | +189.0% | -28.8% | +231.7% | 
| All-Time | All-Time | -24.2% | +3508.4% | -28.8% | +4041.2% | 
JAZZ Accounts Payable History
| Date | Annual | Quarterly | 
|---|---|---|
| Jun 2025 | -  | $89.37M(-6.8%)  | 
| Mar 2025 | -  | $95.93M(+23.2%)  | 
| Dec 2024 | $77.87M(-24.2%)  | $77.87M(-8.8%)  | 
| Sep 2024 | -  | $85.42M(-12.0%)  | 
| Jun 2024 | -  | $97.10M(+19.9%)  | 
| Mar 2024 | -  | $80.98M(-21.2%)  | 
| Dec 2023 | $102.75M(+13.2%)  | $102.75M(-6.5%)  | 
| Sep 2023 | -  | $109.85M(+11.6%)  | 
| Jun 2023 | -  | $98.43M(-21.5%)  | 
| Mar 2023 | -  | $125.45M(+38.2%)  | 
| Dec 2022 | $90.76M(-9.5%)  | $90.76M(-11.2%)  | 
| Sep 2022 | -  | $102.25M(+37.9%)  | 
| Jun 2022 | -  | $74.16M(+1.1%)  | 
| Mar 2022 | -  | $73.34M(-26.9%)  | 
| Dec 2021 | $100.30M(+272.2%)  | $100.30M(+57.2%)  | 
| Sep 2021 | -  | $63.81M(-1.6%)  | 
| Jun 2021 | -  | $64.83M(-16.6%)  | 
| Mar 2021 | -  | $77.74M(+188.5%)  | 
| Dec 2020 | $26.95M(-43.3%)  | $26.95M(-59.8%)  | 
| Sep 2020 | -  | $67.06M(+34.0%)  | 
| Jun 2020 | -  | $50.04M(-24.5%)  | 
| Mar 2020 | -  | $66.31M(+39.5%)  | 
| Dec 2019 | $47.55M(+17.1%)  | $47.55M(-32.2%)  | 
| Sep 2019 | -  | $70.10M(-14.7%)  | 
| Jun 2019 | -  | $82.22M(+92.7%)  | 
| Mar 2019 | -  | $42.67M(+5.1%)  | 
| Dec 2018 | $40.60M(+66.6%)  | $40.60M(+8.6%)  | 
| Sep 2018 | -  | $37.37M(+19.1%)  | 
| Jun 2018 | -  | $31.38M(-33.1%)  | 
| Mar 2018 | -  | $46.93M(+92.6%)  | 
| Dec 2017 | $24.37M(+8.7%)  | $24.37M(-18.7%)  | 
| Sep 2017 | -  | $29.97M(+5.1%)  | 
| Jun 2017 | -  | $28.53M(-2.1%)  | 
| Mar 2017 | -  | $29.14M(+30.0%)  | 
| Dec 2016 | $22.41M(+2.8%)  | $22.41M(+27.2%)  | 
| Sep 2016 | -  | $17.63M(-37.9%)  | 
| Jun 2016 | -  | $28.41M(-12.9%)  | 
| Mar 2016 | -  | $32.62M(+49.6%)  | 
| Date | Annual | Quarterly | 
|---|---|---|
| Dec 2015 | $21.81M(-13.2%)  | $21.81M(-25.1%)  | 
| Sep 2015 | -  | $29.12M(+10.3%)  | 
| Jun 2015 | -  | $26.41M(-3.3%)  | 
| Mar 2015 | -  | $27.32M(+8.7%)  | 
| Dec 2014 | $25.13M(+19.6%)  | $25.13M(-15.3%)  | 
| Sep 2014 | -  | $29.67M(-8.9%)  | 
| Jun 2014 | -  | $32.55M(-55.1%)  | 
| Mar 2014 | -  | $72.54M(+245.3%)  | 
| Dec 2013 | $21.00M(+32.2%)  | $21.00M(-6.4%)  | 
| Sep 2013 | -  | $22.43M(+10.1%)  | 
| Jun 2013 | -  | $20.37M(-35.6%)  | 
| Mar 2013 | -  | $31.63M(+99.1%)  | 
| Dec 2012 | $15.89M(+209.7%)  | $15.89M(-22.6%)  | 
| Sep 2012 | -  | $20.54M(-40.5%)  | 
| Jun 2012 | -  | $34.51M(+152.1%)  | 
| Mar 2012 | -  | $13.69M(+166.9%)  | 
| Dec 2011 | $5.13M(+68.2%)  | $5.13M(-39.4%)  | 
| Sep 2011 | -  | $8.46M(+81.4%)  | 
| Jun 2011 | -  | $4.67M(+27.9%)  | 
| Mar 2011 | -  | $3.65M(+19.6%)  | 
| Dec 2010 | $3.05M(+41.3%)  | $3.05M(-21.6%)  | 
| Sep 2010 | -  | $3.89M(-39.2%)  | 
| Jun 2010 | -  | $6.40M(+64.8%)  | 
| Mar 2010 | -  | $3.88M(+80.0%)  | 
| Dec 2009 | $2.16M(-62.4%)  | $2.16M(-58.8%)  | 
| Sep 2009 | -  | $5.24M(+28.6%)  | 
| Jun 2009 | -  | $4.07M(-10.5%)  | 
| Mar 2009 | -  | $4.55M(-20.6%)  | 
| Dec 2008 | $5.74M(+100.8%)  | $5.74M(-13.3%)  | 
| Sep 2008 | -  | $6.61M(-22.4%)  | 
| Jun 2008 | -  | $8.52M(-4.4%)  | 
| Mar 2008 | -  | $8.91M(+212.1%)  | 
| Dec 2007 | $2.86M(-47.5%)  | $2.86M(-0.6%)  | 
| Sep 2007 | -  | $2.87M(-32.7%)  | 
| Jun 2007 | -  | $4.27M(+35.7%)  | 
| Mar 2007 | -  | $3.15M(-42.2%)  | 
| Dec 2006 | $5.44M(+13.7%)  | $5.44M(+13.7%)  | 
| Dec 2005 | $4.79M  | $4.79M  | 
FAQ
- What is Jazz Pharmaceuticals plc annual accounts payable?
 - What is the all-time high annual accounts payable for Jazz Pharmaceuticals plc?
 - What is Jazz Pharmaceuticals plc annual accounts payable year-on-year change?
 - What is Jazz Pharmaceuticals plc quarterly accounts payable?
 - What is the all-time high quarterly accounts payable for Jazz Pharmaceuticals plc?
 - What is Jazz Pharmaceuticals plc quarterly accounts payable year-on-year change?
 
What is Jazz Pharmaceuticals plc annual accounts payable?
The current annual accounts payable of JAZZ is $77.87M
What is the all-time high annual accounts payable for Jazz Pharmaceuticals plc?
Jazz Pharmaceuticals plc all-time high annual accounts payable is $102.75M
What is Jazz Pharmaceuticals plc annual accounts payable year-on-year change?
Over the past year, JAZZ annual accounts payable has changed by -$24.88M (-24.22%)
What is Jazz Pharmaceuticals plc quarterly accounts payable?
The current quarterly accounts payable of JAZZ is $89.37M
What is the all-time high quarterly accounts payable for Jazz Pharmaceuticals plc?
Jazz Pharmaceuticals plc all-time high quarterly accounts payable is $125.45M
What is Jazz Pharmaceuticals plc quarterly accounts payable year-on-year change?
Over the past year, JAZZ quarterly accounts payable has changed by -$7.73M (-7.96%)